in the Laboratory Four risk or hazard groups are often used to categorize biological agents based on several key factors associated with their inherent characteristics. These are:
• ability to cause disease
• severity of disease • likelihood of spreading to the wider community • availability of prophylaxis or treatment • These groups are then often associated with an equivalent biosafety level (BSL; also known as containment level). • Each BSL (ranging from levels 1 to 4) has a specific set of facility and operational requirements that must be complied with before work with the associated biological agents can be started. • Most routine microbiological analytical work is undertaken in laboratories operated at BSL-2. Although biological agents handled at BSL-2 can cause disease, these typically present a low-to-moderate risk to employees and are unlikely to spread to the wider community because effective treatment or prophylaxis is available. 1,2 • Examples of these include common bacteria such as Staphylococcus aureus, Mycobacterium fortuitum, and Acinetobacter baumannii as well as viruses such as respiratory syncytial virus and norovirus. Fungal isolates such as Aspergillus fumigatus and Microsporum species also fall into this category. Many other examples exist and are listed by most national regulatory bodies as well as by international agencies RISK ASSESSMENT • The aim of a risk assessment is to decide whether appropriate control measures are in place to eliminate or effectively control risks, or to determine whether more are required. The first step in assessing risk from biological agents in the laboratory is to identify and characterize the hazard(s) (ie, sources of harm), the nature of that harm, who might be affected, and how they may be harmed (ie, what they are doing and what could happen to cause harm). Therefore, it is necessary to identify • What biological agents will be used • The activities or procedures to be undertaken, including whether sharps are used, and the potential for causing an exposure, for example, to generate aerosols or splash • The potential health consequences to both laboratory personnel and others who could be exposed Characterizing Biohazards When making a biological risk assessment, the hazards relate directly to the biological agents to be handled. The risk associated with a biological agent will be dependent on several key factors including • the likelihood of infection if exposed • severity of disease (morbidity or mortality) • infectious dose • route(s) of transmission (natural versus laboratory; see in the following text) • communicability/R0 (basic reproduction rate—used to measure the transmission potential of a disease) • epidemiology (exotic or endemic) • effective prophylaxis and treatments (availability, practical, appropriate) • susceptibility of local population (naive) Characterizing Biohazards Other factors that should be considered can include • environmental robustness (persistence outside of host/culture conditions) of the biological agent • natural host range (ie, coming across agents in laboratory not normally encountered), such as rabies being exotic in United Kingdom but endemic in mainland Europe and multi-drug-resistant tuberculosis (MDR TB) considered a greater risk pathology in laboratories at an inner city compared to a rural location • zoonosis • history of laboratory-acquired infection Characterizing Biohazards • susceptibility of staff working in the laboratory (immunocompromised) • symptoms (possibility of asymptomatic disease) • shedding (likelihood and type) • official control (is the agent on a national notifiable disease database, subject to human, plant, animal, or other regulations) • the concentration and volume of the biological agent to be handled Percutaneous Within the laboratory, routes of percutaneous transmission can include • sharps injury such as needles, broken glass, scalpel blades • splashing of the mucous membranes of the eye, nose, or mouth • contamination of unprotected skin lesions, for example, eczema • animal bites or scratches • presence of a vector, for example, biting or piercing insects Contact
• Direct contact with microbiologically contaminated objects or
surfaces (fomites) can readily result in • ingestion of microorganisms, typically after pick up and hand- to-mouth transfer • their contact with mucus membranes • contact with the skin (commonly through broken skin but can occur via contact with intact skin) Airborne
• The airborne route of exposure is commonly implicated in
occupational exposures to all types of hazards including chemicals, nonbiological particulates, and bioaerosols. It is also an exposure that can be readily controlled in the laboratory setting using good laboratory techniques and effective engineering solutions, especially ventilation controls. Failure to do this can result in inhalation of infectious aerosols, conjunctival exposure, inhalation of infectious aerosols followed by swallowing/ingestion (eg, with norovirus), and droplet exposure. Infectious Dose and Environmental Robustness • The ability of a pathogen to cause infection requires its contact with susceptible host receptors (a combination of routes of transmission and exposure, as mentioned earlier) in a sufficient quantity, that is, at an infectious dose. • Data on infectious dose for the wide range of human pathogens are limited. However, some notable examples illustrate the importance of taking this into consideration. • Escherichia coli is an ubiquitous bacterium. Most E coli strains can cause minor infection via the oral route (hand-to-mouth transfer) but require a high dose to do so; therefore, it is safe to work with them in a general-purpose microbiology laboratory (BSL-2) • using routine laboratory precautions. Disabled strains are commonly used tools in laboratory work, especially in genetic and molecular biology modifications and because of this attenuation, they are of minimal hazard (equivalent of BSL-1). EXAMPLES OF LABORATORY ACTIVITIES AND INHERENT RISK Estimating the Risks
• To estimate the risks associated with the handling of
microorganisms, the following need to be considered: consequence of release, consequence of exposure, likelihood of exposure, what could go wrong, and how likely it would be to go wrong. Consequence of Release • Considerations in determining the consequences if the biological agent was released can include • impact/consequence • environmental survival • natural distribution (of the agent in the country) • novelty (new or emerging biological agent, eg, pandemic influenza) • country preparedness (public health context) • epidemiology (endemic, exotic) Consequence of Exposure • The main exposure risks associated with working in this environment are therefore well identified, with some of these reports extending back many years. Some key examples are presented in the following text and provide an international insight into LAIs that help to put in perspective the biological agents implicated in these exposures and how they occurred. Most are based on human error, rather than failure of engineering controls.
Analysis of Used Disinfectants and Antiseptics Correlated With The Occurrence of Nosocomial Infections - Clinical Hospital Stip, Republic of Macedonia in Period of 2007 - 2011